|
As it is unknown which device is directly implicated in this paralysis event, the following devices will also be included in this report: catalog #plc121400 serial # (b)(6)/ udi # (b)(4).Catalog #plc181400/ serial # (b)(6) udi # (b)(4).H6: code c19-a review of the manufacturing records indicated the lots met all pre-release manufacturing specifications.As the device was not accessible, the product history review (phr) review was the extend of the investigation.No device problem was found per review of these records.H6: code c20 - the devices remain implanted and, therefore, was not available for direct analysis by gore.H6: code a24- used to capture reported stroke event without any identified device issue, cause remains unknown.It should be noted that, per the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and / or require intervention include, but are not limited to, neurologic damage, local or systemic (e.G., stroke, paraplegia, paraparesis).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
On (b)(6) 2025, the patient underwent an endovascular procedure to treat an aneurysm, utilizing gore® excluder® conformable aaa endoprosthesis (trunk ipsilateral component) and gore® excluder® aaa endoprosthesis (4 contralateral leg components).The patient tolerated the procedure.It was reported on (b)(6) 2025, the patient presented with leg paralysis.The patient was treated with vasopressor medication to increase blood flow.It was also reported there was no spinal cord ischemia, and neurologist believes full leg function will return.The cause of paralysis is unknown.There were no issues noted during the initial implant procedure.No further patient or case information is available.
|